Walleye Trading
ARNA

Walleye Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Walleye Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-33,100
Closed -$3.08M – 6179
2021
Q4 		$3.08M Sell
33,100
-58,900
-64% -$3.88M 0.01% 1320
2021
Q3 		$5.48M Buy
92,000
+80,300
+686% +$4.74M 0.02% 877
2021
Q2 		$798K Sell
11,700
-20,700
-64% -$1.35M ﹤0.01% 2390
2021
Q1 		$2.25M Buy
32,400
+11,000
+51% +$846K 0.01% 1244
2020
Q4 		$1.64M Buy
21,400
+20,300
+1,845% +$1.52M 0.01% 1551
2020
Q3 		$82K Buy
+1,100
New +$73.3K ﹤0.01% 3472
2020
Q1 		– Sell
-2,800
Closed -$127K – 4788
2019
Q4 		$127K Buy
2,800
+2,300
+460% +$109K ﹤0.01% 3440
2019
Q3 		$23K Sell
500
-500
-50% -$28.1K ﹤0.01% 3741
2019
Q2 		$59K Sell
1,000
-1,900
-66% -$98.2K ﹤0.01% 3488
2019
Q1 		$130K Sell
2,900
-4,200
-59% -$193K ﹤0.01% 3320
2018
Q4 		$277K Buy
+7,100
New +$279K ﹤0.01% 3055

Walleye Trading's ARNA Position: Q2 2021 in Review

Walleye Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 14,862 shares — an estimated $969K sold.

Walleye Trading first reported a position in ARNA in Q2 2015 and held it in 6 quarters. The position peaked at $1.03M in Q1 2021. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Walleye Trading reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 14,862 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $969K.
  • Walleye Trading first reported a position in Arena Pharmaceuticals Inc in Q2 2015 and held it in 6 quarters.
  • Walleye Trading's Arena Pharmaceuticals Inc position peaked at $1.03M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.